Alcohol Addiction – Pipeline Review, 2024

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction

1.1. ReportOverview

2. Alcohol Addiction - Overview

3. Executive Summary

4. Alcohol Addiction : Pipeline Assessment

4.1. By Stage ofDevelopment

4.2. By Route ofAdministration

4.3. By DrugClass

4.4. By MoleculeType

4.5. By TherapyArea / Indication

4.6. By DrugTarget

4.7. By Sponsor

5. Alcohol Addiction: Company & Drug Profiles

5.1. Clinical Stage

5.1.1. ADX71441– ADDEX THERAPEUTICS

5.1.1.1. Company Overview

5.1.1.2. Product Description

5.1.1.3. R&D Status & Development Activities

5.1.1.4. Mechanism of Action

5.1.1.5. Molecule Type

5.1.1.6. Stage of Development

5.1.1.7. Indications

5.1.1.8. Route of Administration

5.1.1.9. Funding

5.1.2. CM-1212 – Curemark LLC

5.1.2.1. Company Overview

5.1.2.2. Product Description

5.1.2.3. R&D Status & Development Activities

5.1.2.4. Mechanism of Action

5.1.2.5. Molecule Type

5.1.2.6. Stage of Development

5.1.2.7. Indications

5.1.2.8. Route of Administration

5.1.2.9. Funding

5.1.3. Mifepristone – The Scripps Research Institute

5.1.3.1. Company Overview

5.1.3.2. Product Description

5.1.3.3. R&D Status & Development Activities

5.1.3.4. Mechanism of Action

5.1.3.5. Molecule Type

5.1.3.6. Stage of Development

5.1.3.7. Indications

5.1.3.8. Route of Administration

5.1.3.9. Funding

5.1.4. Others

5.2. Preclinical

5.2.1. Company Overview

5.2.2. Product Description

5.2.3. R&D Status & Development Activities

5.2.4. Mechanism of Action

5.2.5. Molecule Type

5.2.6. Indications

5.2.7. Route of Administration

5.2.8. Funding

6. Alcohol Addiction: An Overview on Dormant & Discontinued PipelineCandidates

6.1. Overview

6.2. ProductDescription

6.3. Reason forDiscontinuation

7. Alcohol Addiction: Additional Key Insights

7.1.Epidemiology Overview: Alcohol Addiction

7.2. CurrentMarket Scenario: Alcohol Addiction Therapeutics

8. Alcohol Addiction: News, Press Releases and Conference Details

Note:

1) This Table of Content is tentative and subject to change as the research progresses.

2) Please note that the drug candidates included as examples were in the pipeline when this TOC was designed and their status might have changed since then.